Bumi Serpong Damai Tbk vs Merck Tbk. — how do they compare? Bumi Serpong Damai Tbk trades at Rp565 (market cap 11.75T, 5.18M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 25.1K 24h volume). The key difference: Bumi Serpong Damai Tbk is far larger — about 6.9× Merck Tbk.'s market cap, and Bumi Serpong Damai Tbk is more actively traded (5.18M versus 25.1K). Which is the better fit depends on your goals.
| BSDE | MERK | |
|---|---|---|
Market Cap | 11.75T | 1.7T |
Volume | 5.18M | 25.1K |
Lot | 51.79K | 251 |
Turnover | 2.92B | 96.31M |
Average Price | 563.95 | 3,836.85 |
Value | 2.92B | 96.31M |
Indicative Equilibrium Price | 560 | 3,850 |
Indicative Equilibrium Volume | 166 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bumi Serpong Damai Tbk (the company) was established on January 16, 1984 based on the Notarial Deed No. 50 of Benny Kristianto, S.H., a public notary in Jakarta. The Company’s articles of association has been amended several times, most recently by notarial deed No. 01 of Tarwiyah, S.H., dated Jan 25, 2008, concerning company's public offering.
Read more on BSDE →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →